BIOMAT Database Logo BIOMAT Database Logo

[Long-term treatment of hypertension with a beta blocking agent (sotalol) alone or in combination with a saluretic agent]. 1978

A Verniory, and M Staroukine, and F Delwiche

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013015 Sotalol An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias. Darob,MJ-1999,Sotalol Hydrochloride,Sotalol Monohydrochloride,MJ 1999,MJ1999
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

A Verniory, and M Staroukine, and F Delwiche
Long-term therapy of arterial hypertension with nifedipine given alone or in combination with a beta-adrenoceptor blocking agent.
January 1982, European journal of clinical pharmacology,
A Verniory, and M Staroukine, and F Delwiche
[Long-term management of arterial hypertension using a beta-adrenolytic agent in combination with a saluretic].
April 1979, Die Medizinische Welt,
A Verniory, and M Staroukine, and F Delwiche
Sotalol: another beta adrenergic blocking agent?
January 1979, Journal of clinical pharmacology,
A Verniory, and M Staroukine, and F Delwiche
[Nadolol, a long-term acting beta blocking agent, in the treatment of essential arterial hypertension].
September 1982, Cardiologia (Rome, Italy),
A Verniory, and M Staroukine, and F Delwiche
Sotalol, a pure beta-adrenergic blocking agent for treatment of essential hypertension and other cardiovascular diseases.
January 1979, Journal of clinical pharmacology,
A Verniory, and M Staroukine, and F Delwiche
Long-term treatment of hypertension with guanfacine alone and in combination therapy.
January 1980, British journal of clinical pharmacology,
A Verniory, and M Staroukine, and F Delwiche
Sotalol: a new, safe beta adrenergic receptor blocking agent.
August 1968, The American journal of cardiology,
A Verniory, and M Staroukine, and F Delwiche
[Long-term treatment of hypertension with a beta blocker-diuretic combination].
November 1983, ZFA. Zeitschrift fur Allgemeinmedizin,
A Verniory, and M Staroukine, and F Delwiche
Long-term use of prazosin in combination or alone for treating hypertension.
August 1977, The Medical journal of Australia,
A Verniory, and M Staroukine, and F Delwiche
[Combined treatment of arterial hypertension. Comparison of a beta-blocker plus a saluretic combination with beta-blocker].
February 1983, MMW, Munchener medizinische Wochenschrift,
Copied contents to your clipboard!